Jefferies Financial Group Portfolio holdings
Jefferies Financial Group is the investment banking and capital markets company that was known as Leucadia National until 2018, when it took the name of the bank it merged with in 2013. Leucadia traces back to Ian Cumming and Joseph Steinberg, Harvard Business School graduates who started out at the investment bank Carl Marks & Company and in 1979 took control of Talcott National, renaming it Leucadia the next year. As a holding company it bought and resold businesses, such as the insurer Colonial Penn, acquired in 1991 and sold in two pieces in 1997, and the telecoms company WilTel, acquired in 2003 and sold in 2005. Jefferies itself grew from a small equities trading shop into a full-service investment bank, and Richard Handler became chief executive of the combined company in 2013.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$380M |
| 2 |
Apple
AAPL
|
+$147M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$106M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$66.5M |
| 5 |
Iris Energy
IREN
|
+$58.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$131M |
| 2 |
Ashland
ASH
|
+$106M |
| 3 |
Analog Devices
ADI
|
+$83.9M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$78.3M |
| 5 |
Johnson Controls International
JCI
|
+$70.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.01% |
| 2 | Healthcare | 12.03% |
| 3 | Technology | 11.01% |
| 4 | Consumer Discretionary | 5.82% |
| 5 | Financials | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Vanguard Real Estate ETF
VNQ
$37.7B
| $80.1M | 0.53% |
831,143
+29,006
| +4% | +$2.77M |
2023 Q3
11 quarters
|
|
27
Vanguard S&P 500 ETF
VOO
$1.02T
| $79.1M | 0.52% |
115,167
+27,499
| +31% | +$18.3M |
2022 Q4
14 quarters
|
|
28
Flex
FLEX
$32B
| $75.8M | 0.5% |
467,872
+241,237
| +106% | +$29.3M |
2025 Q3
3 quarters
|
|
29
ARK Genomic Revolution ETF
ARKG
$2.05B
| $75.7M | 0.5% |
1,800,113
+1,049,292
| +140% | +$33.4M |
2026 Q1
1 quarter
|
|
30
CALL
SPDR Gold Trust
GLD
$130B
| $72.3M | 0.48% |
196,200
-5,369,400
| -96% | -$2.22B |
2023 Q1
13 quarters
|
|
31
PPL Corp
PPL
$26.8B
| $70.3M | 0.46% |
1,933,612
+458,841
| +31% | +$17M |
2025 Q4
2 quarters
|
|
32
Elevance Health
ELV
$91.1B
| $69.9M | 0.46% |
180,619
+34,972
| +24% | +$13M |
2022 Q4
14 quarters
|
|
33
AbbVie
ABBV
$521B
| $67.5M | 0.44% |
268,264
+59,905
| +29% | +$12.9M |
2024 Q1
9 quarters
|
|
34
Hillman Solutions
HLMN
$1.52B
| $67.3M | 0.44% |
7,976,734
-11,469
| -0.1% | -$91.2K |
2021 Q3
19 quarters
|
|
35
PUT
Intel
INTC
$350B
| $67.1M | 0.44% |
480,200
-993,600
| -67% | -$100M |
2025 Q3
3 quarters
|
|
36
NNN REIT
NNN
$7.87B
| $66.6M | 0.44% |
1,431,000
+889,325
| +164% | +$39.7M |
2025 Q3
3 quarters
|
|
37
Immatics
IMTX
$1.1B
| $65.9M | 0.43% |
6,506,802
+1,447,251
| +29% | +$15.3M |
2025 Q3
3 quarters
|
|
|
38
PUT
Iris Energy
IREN
$9.44B
| $65.7M | 0.43% |
1,436,200
-976,000
| -40% | -$50.7M |
2024 Q4
6 quarters
|
|
39
RTX Corp
RTX
$270B
| $65.6M | 0.43% |
345,492
+127,712
| +59% | +$23.4M |
2025 Q4
2 quarters
|
|
40
ASML
ASML
$604B
| $63.7M | 0.42% |
32,000
+31,059
| +3,301% | +$49.4M |
2023 Q2
12 quarters
|
|
41
Tango Therapeutics
TNGX
$3.83B
| $62.8M | 0.41% |
+2,010,534
| New | +$49.7M |
2026 Q2
0 quarters
|
|
42
JPMorgan Chase
JPM
$895B
| $61.5M | 0.41% |
187,957
+90,393
| +93% | +$28.1M |
2022 Q4
14 quarters
|
|
|
43
Iris Energy
IREN
$9.44B
| $60.7M | 0.4% |
1,327,205
+1,122,945
| +550% | +$58.4M |
2025 Q1
5 quarters
|
|
44
Alphabet (Google) Class A
GOOGL
$3.44T
| $59.5M | 0.39% |
166,421
+81,730
| +97% | +$29.4M |
2022 Q4
14 quarters
|
|
45
Seagate
STX
$148B
| $58.2M | 0.38% |
60,306
+48,273
| +401% | +$36.8M |
2025 Q3
3 quarters
|
|
46
Ross Stores
ROST
$72.9B
| $58.1M | 0.38% |
272,995
+73,144
| +37% | +$16.5M |
2023 Q1
13 quarters
|
|
47
PUT
Williams-Sonoma
WSM
$29.8B
| $58M | 0.38% |
+249,000
| New | +$49.3M |
2026 Q2
0 quarters
|
|
48
iShares Biotechnology ETF
IBB
$11.3B
| $57.5M | 0.38% |
302,306
-1
| -0% | -$172 |
2025 Q3
3 quarters
|
|
49
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$51.2B
| $56.4M | 0.37% |
615,651
+55,891
| +10% | +$5.12M |
2022 Q4
14 quarters
|
|
50
Mastercard
MA
$556B
| $55M | 0.36% |
107,074
-119,990
| -53% | -$59.8M |
2022 Q4
14 quarters
|
|
Similar funds
Jefferies Financial Group's Q2 2026 Portfolio in Review
As of Q2 2026, Jefferies Financial Group held 2,149 positions worth $15.2B, up 4% from $14.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Jefferies Financial Group deployed $1.26B of net new capital in Q2 2026, opening 466 new positions and adding to 491 existing holdings. Its largest new stake was CG Oncology: 769,947 shares worth $54.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 61% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Broadcom, an estimated $131M trimmed.
- Jefferies Financial Group's largest Q2 2026 buy was CG Oncology: 769,947 shares worth $54.7M.
- Jefferies Financial Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $380M increase.
- Jefferies Financial Group's biggest Q2 2026 reduction was Broadcom, cutting an estimated $131M.
- Jefferies Financial Group fully exited Ashland in Q2 2026, selling an estimated $106M.
- Jefferies Financial Group's ten largest holdings make up 31% of its $15.2B portfolio in Q2 2026.
- Jefferies Financial Group opened 466 new positions and closed 528 in Q2 2026.
- Jefferies Financial Group's portfolio value rose 4% quarter-over-quarter to $15.2B.
Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.